Nova One Advisor

Global Intrauterine Contraceptive Devices (IUCDs) Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 3483 Format: PDF / PPT / Excel

Content

The global Intrauterine Contraceptive Devices (IUCDs) market garnered revenue around USD XX Billion in 2019 and projected to reach USD 3 Billion in 2027, with at a compound annual growth rate of 10.9% throughout the estimate period from 2020 to 2027.

The increasing awareness about contraceptive methods, increasing number of unintended pregnancies, and government support and initiatives for the prevention of unwanted abortions & pregnancies are set to drive the demand for intrauterine contraceptive devices (IUCDs) during the forecast period.

The technological innovations are leading to effective contraception along with fewer side effects, which are strongly influencing the growth of the market and likely to provide favorable conditions for the growth of the market.

Birth controls have been used since ancient times, but the safe and effective methods from the 20th century are being implemented and available. Contraceptive methods are used to prevent unwanted pregnancy by preventing the natural ovulation cycle or altering the egg fertilization process. Intrauterine contraceptive devices are placed inside the uterus to avoid pregnancy. The device has a string that ensures the correct placement of the equipment inside the uterus and helps in the removal of the device. Intrauterine contraceptive devices can be used for 3,5 and 10 years. These devices are made up of plastic and metal and available in various shapes, such as coil, loop, triangle, and T-shaped.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Intrauterine Contraceptive Devices (IUCDs) market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Intrauterine Contraceptive Devices (IUCDs) market growth.

The global Intrauterine Contraceptive Devices (IUCDs) market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

Bayer AG

Eurogine, S.L.

The Cooper Companies, Inc.

Pfizer Inc.

HLL Lifecare Limited

OCON Healthcare

SMB Corporation

Egemen International

Meril Life Sciences Pvt. Ltd.

Mona Lisa N.V.

Prosan International B.V.

Pregna International Limited

Others

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Type

Hormonal Intrauterine Device:

Copper Intrauterine Device:

By End-User

Hospitals

Gynecology Clinics:

Community Health Care Centers:

Others:

Regional Analysis and Forecast



Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:



North America

? U.S.

? Canada

Europe

? Germany

? U.K.

? Italy

? France

? Rest of EU

Asia Pacific

? China

? India

? Japan

? Southeast Asia

? Rest of APAC

Central & South America

? Brazil

? Argentina

? Rest of Central & South America

Middle East and Africa

? UAE

? Saudi Arabia

? Rest of MEA

  • Insight Code: 3483
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: October 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034